GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Marvel Biosciences Corp (OTCPK:MBCOF) » Definitions » Gross Margin %

MBCOF (Marvel Biosciences) Gross Margin % : 0.00% (As of Jan. 2025)


View and export this data going back to 2023. Start your Free Trial

What is Marvel Biosciences Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Marvel Biosciences's Gross Profit for the three months ended in Jan. 2025 was $-0.20 Mil. Marvel Biosciences's Revenue for the three months ended in Jan. 2025 was $0.00 Mil. Therefore, Marvel Biosciences's Gross Margin % for the quarter that ended in Jan. 2025 was 0.00%.


The historical rank and industry rank for Marvel Biosciences's Gross Margin % or its related term are showing as below:


MBCOF's Gross Margin % is not ranked *
in the Biotechnology industry.
Industry Median: 59.72
* Ranked among companies with meaningful Gross Margin % only.

Marvel Biosciences had a gross margin of % for the quarter that ended in Jan. 2025 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Marvel Biosciences was 0.00% per year.


Marvel Biosciences Gross Margin % Historical Data

The historical data trend for Marvel Biosciences's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Marvel Biosciences Gross Margin % Chart

Marvel Biosciences Annual Data
Trend Jul20 Jul21 Jul22 Jul23 Jul24
Gross Margin %
- - - - -

Marvel Biosciences Quarterly Data
Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Marvel Biosciences's Gross Margin %

For the Biotechnology subindustry, Marvel Biosciences's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Marvel Biosciences's Gross Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Marvel Biosciences's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Marvel Biosciences's Gross Margin % falls into.


;
;

Marvel Biosciences Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Marvel Biosciences's Gross Margin for the fiscal year that ended in Jul. 2024 is calculated as

Gross Margin % (A: Jul. 2024 )=Gross Profit (A: Jul. 2024 ) / Revenue (A: Jul. 2024 )
=0 / 0
=(Revenue - Cost of Goods Sold) / Revenue
=(0 - 0) / 0
=N/A %

Marvel Biosciences's Gross Margin for the quarter that ended in Jan. 2025 is calculated as


Gross Margin % (Q: Jan. 2025 )=Gross Profit (Q: Jan. 2025 ) / Revenue (Q: Jan. 2025 )
=-0.2 / 0
=(Revenue - Cost of Goods Sold) / Revenue
=(0 - 0.198) / 0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Marvel Biosciences  (OTCPK:MBCOF) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Marvel Biosciences had a gross margin of % for the quarter that ended in Jan. 2025 => No sustainable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Marvel Biosciences Gross Margin % Related Terms

Thank you for viewing the detailed overview of Marvel Biosciences's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Marvel Biosciences Business Description

Traded in Other Exchanges
Address
505 - 8th Avenue SW, Suite 420, Calgary, AB, CAN, T2P1G2
Marvel Biosciences Corp is a life sciences company focused on the discovery and development of a synthetic derivative compound of a known drug. It has developed several new chemical entities, using synthetic chemical derivatives of known, off-patent drugs, that inhibit the A2a adenosine receptor with application to neurological diseases (depression & anxiety, Alzheimer's, ADHD), and the non-neurological conditions of cancer and non-alcoholic steatohepatitis. Marvel is also exploring additional undisclosed targets to expand its asset pipeline.